義大癌治療醫院胃腸肝膽科主任


專長

內科學、食道癌、胃癌、大腸癌、診斷及治療性內視鏡術、肝腫瘤、膽道胰臟疾病、肝炎、腹部超音波、大腸息肉症、治療性內視鏡術、肝腫瘤燒灼治療、逆流性食道炎、消化道潰瘍、消化道出血、超音波學、慢性B型及C型肝炎、肝腫瘤、膽道胰臟疾病


曾政豪

學經歷

現任:義大癌治療醫院肝膽胃腸科主任
教育部部定講師
義癌治療醫院肝膽胃腸科主治醫師
台大醫院腸胃科研究員
台大醫院內科部住院醫師
日本東京國立癌病中心內視鏡研究員
義大醫院兼任主治醫師

論文

1. C-H Tseng, K-L Liu, J-M Liou, H-P W, M-S Wu*
Abdominal distension in a patient with Crohn's disease. GUT. 2009;58;346.

2. C-H Tseng, Kao-Lang Liu, Jyh-Ming Liou, Hsiu-Po Wang *
A 61-year-old male with abdominal pain for 6 months. Gut 2010;59:147

3. C-H Tseng, Wen-Lun Wang, Tsung-Chun Lee, Tzong-Hsi Lee, Hsiu-Po Wang*.
Ileal obstruction in a 73-year-old woman. Gut 2009;58:741

4. Hsu YC, Chung CS, Tseng CH, Lin TL, Liou JM, Wu MS, Hu FC, Wang HP*.
Delayed Endoscopy as a Risk Factor for In-hospital Mortality in Cirrhotic .with Acute Variceal Hemorrhage. J Gastroenterol Hepatol 2009: 24 (7) 1294~1299

5. Hsu YC, Liou JM, Chung CS, Tseng CH, Lin TL, Chen CC, Wu MS, Wang HP*.
Early risk stratification with simple clinical parameters for cirrhotic patients with acute upper gastrointestinal bleeding. Am J Emerg Med 2010;28(8):884-90

6.  Hsu YC, Mo LR, Chang CY, Perng DS, Tseng CH, Lo GH, Tai CM, Lin CW, Hsu CC, Hsu CY, Huang SC, Lin JT*.
Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation. Antivir Ther. 2012;17(4):605-12.

7. Lee CT, Chang CY, Tai CM, Wang WL, Tseng CH, Hwang JC, Lin JT.
Endoscopic submucosal dissection for early esophageal neoplasia: a single center experience in South Taiwan.J Formos Med Assoc. 2012 Mar;111(3):132-9

8. Liou JM, Chen CC, Chang CY, Chen MJ, Fang YJ, Lee JY, Chen CC, Hsu SJ, Hsu YC, Tseng CH, Tseng PH, Chang L, Chang WH, Wang HP, Shun CT, Wu JY,Lee YC, Lin JT, Wu MS*; 
on behalf of the Taiwan Helicobacter Consortium.Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial. J Antimicrob Chemother. 2013 Feb;68(2):450-6

9. Hsu YC, Wu CY, Chang CY, Tai CM, Tseng CH, Perng DS, Mo LR, LinJT.
Pretreatment viral DNA stratifies mortality risk in patients receiving antiviral therapy for severe acute exacerbation of chronic hepatitis B. Antivir Ther. 2013;18(2):221-8

10. Liou JM, Chen CC, Chen MJ, Chen CC, Chang CY, Fang YJ, Lee JY, Hsu SJ, Luo JC, Chang WH, Hsu YC, Tseng CH, Tseng PH, Wang HP, Yang UC, Shun CT,Lin JT, Lee YC, Wu MS; 
for the Taiwan Helicobacter Consortium. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet. 2013 Jan 19;381(9862):205-13.

11. Wang WL, Wang CP, Wang HP, Lee CT, Chang CY, Tai CM, Tseng CH, Hwang TZ, Wang CC, Lo JL, Tseng PH, Chiu HM, Lee JM, Ko JY, Lou PJ, Wu MS, Lee YC, Lin JT.
The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer. Oral Oncol. 2013 Aug;49(8):808-13.

12. Hsu YC, Wu CY, Lane HY, Chang CY, Tai CM, Tseng CH, Lo GH, Perng DS, Lin JT, Mo LR.
Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B.J Antimicrob Chemother. 2014 Jul;69(7):1920-7. doi: 10.1093/jac/dku041. Epub 2014 Feb 26.

13. Liou JM, Chang CY, Chen MJ, Chen CC, Fang YJ, Lee JY, Wu JY, Luo JC, Liou TC, Chang WH, Tseng CH, Wu CY, Yang TH, Chang CC, Wang HP, Sheu BS, Lin JT, Bair MJ, Wu MS;
Taiwan Gastrointestinal Disease and Helicobacter Consortium. The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.PLoS One. 2015 May 5;10(5):e0124199. doi: 10.1371/journal.pone.0124199. eCollection 2015.

14. Cheng-Hao Tseng, Yao-Chun Hsu1, Chi-Yang Chang , Chih-Wen Lin, Jaw-Town Lin, Lein-Ray Mo
Change of insulin resistance in hepatitis C virus-infected patients receiving pegylated interferon plus ribavirin. Advances in Digestive Medicine. DOI: http://dx.doi.org/10.1016/j.aidm.2014.12.003

15. Liou JM, Chen CC, Chang CY, Chen MJ, Chen CC, Fang YJ, Lee JY, Yang TH, Luo JC, Wu JY, Liou TC, Chang WH, Hsu YC, Tseng CH, Chang CC, Bair MJ, Liu TY, Hsieh CF, Tsao FY, Shun CT, Lin JT, Lee YC, Wu MS;
Taiwan Gastrointestinal Disease and Helicobacter Consortium.Gut. 2015 Sep 3. pii: gutjnl-2015-310142. doi: 10.1136/gutjnl-2015-310142. [Epub ahead of print]Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial.

16.Liou JM, Bair MJ, Chen CC, Lee YC, Chen MJ, Chen CC, Tseng CH, Fang YJ, Lee JY, Yang TH, Luo JC, Wu JY, Chang WH, Chang CC, Chen CY, Chen PY, Shun CT, Hsu WF, Hung HW, Lin JT, Chang CY, Wu MS;
Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial. Taiwan Gastrointestinal Disease and Helicobacter Consortium..Am J Gastroenterol. 2016 Mar;111(3):381-7. doi: 10.1038/ajg.2015.439.

17.Tseng CM, Liao WC, Chang CY, Lee CT, Tseng CH, Hsu YC, Lin JT.
Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: A population-based study in Taiwan. Pancreatology. 2017 Jan - Feb;17(1):76-82.

18.Liou JM, Fang YJ, Chen CC, Bair MJ, Chang CY, Lee YC, Chen MJ, Chen CC, Tseng CH, Hsu YC, Lee JY, Yang TH, Luo JC, Chang CC, Chen CY, Chen PY, Shun CT, Hsu WF, Hu WH, Chen YN, Sheu BS, Lin JT, Wu JY, El-Omar EM, Wu MS;
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Taiwan Gastrointestinal Disease and Helicobacter Consortium..ancet. 2016 Nov 12;388(10058):2355-2365.

19.Chen CC, Hsu YC, Lee CT, Hsu CC, Tai CM, Wang WL, Tseng CH, Hsu CT, Lin JT, Chang CY.
Central Obesity and H. pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population. PLoS One. 2016 Dec 9;11(12):e0167815.

20.Hsu YC, Mo LR, Chang CY, Wu MS, Yang TH, Kao JH, Chen CC, Tseng CH, Tai CM, Lin CW, Wu CY, Lin JT.J
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy. Gastroenterol Hepatol. 2017 Jan 25. doi: 10.1111/jgh.13728. [Epub ahead of print]

21.Cheng-Hao Tseng, Chi-Yang Chang, Lein-Ray Mo, Jaw-Town Lin ,Chi- Ming Tai, Daw-Shyong Perng, Chih-Wen Lin, Yao-Chun Hsu .
Acoustic Radiation Force Impulse Elastography with APRI and FIB-4 to Identify Significant Liver Fibrosis in Chronic Hepatitis B Patients .Annals of Hepatology(In press)